The role of nerve growth factor in neuropathic pain inhibition produced by resiniferatoxin treatment in the dorsal root ganglia

Neurosurgery

Volumn 73, Issue 1, 2013, Pages 158-165

  Tender, Gabriel C ^a   Li, Yuan Yuan ^a   Cui, Jian Guo ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

NGF; Pain; Rat; Sciatic nerve injury; TrkA; Vanilloid receptor 1

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; PROTEIN P75; PROTEIN TYROSINE KINASE A; RESINIFERATOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD SENSATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HEAT SENSATION; HYPOALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MOTOR PERFORMANCE; NERVE CELL; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE INJURY; SENSORIMOTOR FUNCTION; SPINAL GANGLION; TOUCH;

ANALGESICS; ANIMALS; CELLS, CULTURED; DITERPENES; GANGLIA, SPINAL; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; NEURAL INHIBITION; NEURALGIA; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84880573191     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000429850.37449.c8     Document Type: Article

References (42)

1. Varga A, Bölcskei K, Szöke E, et al. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo. Neuroscience. 2006;140(2):645-657
2. Sevcik MA, Ghilardi JR, Peters CM, et al. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 2005;115(1-2):128-141
3. Mousa SA, Cheppudira BP, Shaqura M, et al. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain. 2007;130(pt 2): 502-513
4. Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F. The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci U S A. 2007;104(8):2985-2990
5. Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res. 2005;65(20):9426-9435
6. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 1999;51(2):159-212
7. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609-642
8. Delcroix JD, Valletta J, Wu C, et al. Trafficking the NGF signal: implications for normal and degenerating neurons. Prog Brain Res. 2004;146:3-23
9. Obata K, Katsura H, Sakurai J, et al. Suppression of the p75 neurotrophin receptor in uninjured sensory neurons reduces neuropathic pain after nerve injury. J Neurosci. 2006;26(46):11974-11986
10. Bentley CA, Lee KF. p75 is important for axon growth and schwann cell migration during development. J Neurosci. 2000;20(20):7706-7715
11. Blöchl A, Blumenstein L, Ahmadian MR. Inactivation and activation of Ras by the neurotrophin receptor p75. Eur J Neurosci. 2004;20(9):2321-2335
12. Tender GC, Li YY, Cui JG. Vanilloid receptor 1-positive neurons mediate thermal hyperalgesia and tactile allodynia. Spine J. 2008;8(2):351-358
13. Fang X, Djouhri L, McMullan S, et al. trkA is expressed in nociceptive neurons and influences electrophysiological properties via Nav1.8 expression in rapidly conducting nociceptors. J Neurosci. 2005;25(19):4868-4878
14. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997; 389(6653):816-824
15. Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21(3):531-543
16. Olah Z, Szabo T, Karai L, et alLigand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor J Biol Chem. 2001;276(14): 11021-11030
17. Brown DC, Iadarola MJ, Perkowski SZ, et al. Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology. 2005;103(5):1052-1059
18. Karai L, Brown DC, Mannes AJ, et al. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest. 2004;113(9):1344-1352
19. Tender GC, Kaye AD, Li YY, Cui JG. Neurotrophin-3 and tyrosine kinase C have modulatory effects on neuropathic pain in the rat dorsal root ganglia. Neurosurgery. 2011;68(4):1048-1055
20. Gazelius B, Cui JG, Svensson M, Meyerson B, Linderoth B. Photochemically induced ischaemic lesion of the rat sciatic nerve. A novel method providing high incidence of mononeuropathy. Neuroreport. 1996;7(15-17):2619-2623
21. Flatters SJ, Bennett GJ. Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy. Pain. 2004;109(1-2):150-161
22. Ruiz G, Baños JE. The effect of endoneurial nerve growth factor on calcitonin gene-related peptide expression in primary sensory neurons. Brain Res. 2005; 1042(1):44-52
23. Bucelli RC, Gonsiorek EA, Kim WY, et al. Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons. J Pharmacol Exp Ther. 2008;324(3):1172-1180
24. Tender GC, Walbridge S, Olah Z, et al. Selective ablation of nociceptive neurons for elimination of hyperalgesia and neurogenic inflammation. J Neurosurg. 2005; 102(3):522-525
25. Lewin GR, Rueff A, Mendell LM. Peripheral and central mechanisms of NGFinduced hyperalgesia. Eur J Neurosci. 1994;6(12):1903-1912
26. Einarsdottir E, Carlsson A, Minde J, et al. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet. 2004;13(8): 799-805
27. Evans RM, Scott RH, Ross RA. Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. Br J Pharmacol. 2007;152(3):404-413
28. Herzberg U, Eliav E, Dorsey JM, Gracely RH, Kopin IJ. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport. 1997;8(7):1613-1618
29. Davis BM, Albers KM, Seroogy KB, Katz DM. Overexpression of nerve growth factor in transgenic mice induces novel sympathetic projections to primary sensory neurons. J Comp Neurol. 1994;349(3):464-474
30. Yasuda K, Churchill L, Yasuda T, Blindheim K, Falter M, Krueger JM. Unilateral cortical application of interleukin-1beta (IL1beta) induces asymmetry in fos, IL1beta and nerve growth factor immunoreactivity: implications for sleep regulation. Brain Res. 2007;1131(1):44-59
31. Kuno R, Yoshida Y, Nitta A, et al. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 2006;1116(1):12-18
32. Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain. 2000;88(3):239-248
33. Davies AM. Regulation of neuronal survival and death by extracellular signals during development. EMBO J. 2003;22(11):2537-2545
34. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002;36(1):57-68
35. Luo W, Wickramasinghe SR, Savitt JM, Griffin JW, Dawson TM, Ginty DD. A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons. Neuron. 2007;54(5): 739-754
36. Susen K, Blöchl A. Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75. J Mol Med (Berl). 2005;83(9): 720-735
37. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 1996;383(6602):716-719
38. Dobrowsky RT, Carter BD. p75 neurotrophin receptor signaling: mechanisms for neurotrophic modulation of cell stress? J Neurosci Res. 2000;61(3):237-243
39. van Blitterswijk WJ, van der Luit AH, Veldman RJ, VerheijM, Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J. 2003;369(pt 2):199-211
40. Woo NH, Teng HK, Siao CJ, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci. 2005;8(8):1069-1077
41. Blöchl A, Blöchl R. A cell-biological model of p75NTR signaling. J Neurochem. 2007;102(2):289-305
42. Anand U, Otto WR, Casula MA, et al. The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurons. Neurosci Lett. 2006;399(1-2):51-56.